Nutrition & Care Q2 2020 We slightly increased sales in the Nutrition & Care segment compared with the second quarter of 2019. This was driven by considerable sales growth in the Nutrition & Health division, while sales in the Care Chemicals division were on a level with the prior-year quarter. (XLS:) XLS Factors influencing sales in Q2 2020 – Nutrition & Care Nutrition & Care Care Chemicals Nutrition & Health Volumes 7% 4% 12% Prices (1%) (2%) 2% Portfolio 0% 0% 0% Currencies (2%) (2%) (2%) Sales 4% 0% 12% The slight sales increase was primarily due to higher volumes in both divisions. The significant volumes growth in the Nutrition & Health division was mainly attributable to the aroma ingredients, pharmaceutical and human nutrition businesses. Sales volumes rose slightly in the Care Chemicals division. Higher volumes in the home care, industrial and institutional cleaning and industrial formulators business, as well as in the oleo surfactants and alcohols business contributed to sales growth. Negative currency effects, especially in South America, partially offset this increase. Sales were also negatively impacted by a slightly lower price level. This was largely attributable to lower prices in the home care, industrial and institutional cleaning and industrial formulators business in the Care Chemicals division. Slightly higher prices in the Nutrition & Health division, mainly driven by the animal nutrition business, could not compensate for this decrease. We considerably increased income from operations (EBIT) before special items compared with the prior-year quarter thanks to a significantly higher contribution from the Nutrition & Health division. This was primarily due to higher margins resulting from higher volumes and prices. EBIT before special items in the Care Chemicals division declined slightly, mainly from higher fixed costs due to a one-off contractual payment in the prior-year quarter. (XLS:) XLS Segment data – Nutrition & Care (Million €) Q2 H1 2020 2019 +/– 2020 2019 +/– a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments) b Additions to property, plant and equipment and intangible assets Sales to third parties 1,555 1,495 4% 3,137 3,056 3% of which Care Chemicals 1,007 1,004 0% 2,095 2,099 0% Nutrition & Health 548 491 12% 1,042 957 9% Income from operations before depreciation, amortization and special items 362 318 14% 719 645 11% Income from operations before depreciation and amortization (EBITDA) 359 306 17% 711 626 14% Depreciation and amortizationa 104 99 5% 212 295 (28%) Income from operations (EBIT) 255 207 23% 499 331 51% Special items (1) (13) 92% (11) (111) 90% EBIT before special items 256 220 16% 510 442 15% Assets (June 30) 6,584 6,386 3% 6,584 6,386 3% Investments including acquisitionsb 104 110 (5%) 206 209 (1%) Research and development expenses 37 38 (3%) 74 73 1% back next